The New York Genome Center (NYGC) is an independent, nonprofit academic research institution focused on furthering genomic research that leads to scientific advances and new insights and therapies for patients with neurodegenerative disease, neuropsychiatric disease, and cancer, leveraging our strengths in whole genome sequencing, genomic analysis, and development of genomic tools.

We serve as a nexus for collaboration in genomic research for the New York community and beyond, building on the combined strengths of our faculty, member institutions, scientific working groups, affiliate members, and industry partners.

Central to this commitment is an outstanding faculty who are leading independent research labs based at the NYGC and one of our member institutions. They also support the NYGC scientific mission and engage in research programs that support the NYGC and the wider scientific community.


The ALS Association and
The Tow Foundation Commit
Additional $6 Million
to New York Genome Center

New Funding to Support Center for Genomics of Neurodegenerative Disease

Read More →


David A. Knowles, PhD, Joins the New York Genome Center Core Faculty

Read More →


Neville Sanjana, PhD, Named “Leichtung Family Investigator” for Autism Genomics Research

Read More →


New York Cancer Genomics Research Network Meetings

These monthly meetings, moderated by Harold Varmus, MD, Senior Associate Core Member, NYGC, and Lewis Thomas University Professor of Medicine, Weill Cornell Medicine, bring together leading cancer researchers, clinicians and postdocs from the NYGC’s Institutional Founding Members and other key academic institutions.

Read More →


Developing New Genomic Tools & Technologies

Our scientists are focused on collaborative initiatives in single cell and spatial transcriptomics and the computational methods necessary to understand the underlying biology and disease mechanisms.

Our Technology Innovation Lab is a leader in developing new technologies for enhanced single-cell analysis, including CITE-seq and Cell Hashing, and making them widely accessible to the scientific community.



Furthering Scientific Inquiry

Our outstanding faculty and staff scientists are recognized as innovators in the field, and in the last five years have published over 200 papers in leading scientific journals helping to advance genomic science. They have received many awards and honors, including three prestigious NIH New Innovator Awards. Their important research has provided new insights, including the discovery of dozens of new genes that create cancer resistance and hundreds of genes that impact the human immune system. NYGC researchers have also contributed to the identification of a novel gene associated with ALS, and uncovered new genetic signatures for autism.


NYGC's Affiliate Member Program and Scientific Working Groups

Learn More

Our Member Institutions

Institutional Founding Members

Institutional Associate Members